Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

VanEck Vectors Pharmaceutical ETF (PPH)

Delayed Data
As of 9:52am ET
 -0.1999 / -0.36%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVISä US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Should You Buy Pharma ETFs Now?
Mar 15 / Zacks.com - Paid Partner Content


1 month-0.62% 3 years+0.91%
3 months+6.26% 5 years+10.13%
1 year-0.30% Since inception+11.08%
Data through 03/28/2017

Quote Details

Previous close$55.82
Open day’s range55.62 – 55.80
Net asset value (NAV)55.80 (03/27/2017)
Daily volume2,268
Average volume (3 months)214,364
Data as of 9:52am ET, 03/28/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+10.13%+16.84%
Expense Gross exp ratio0.41%1.33%
Risk 5 year sharpe ratio0.821.11
Net assets$366.5M$3.0B
Average market cap$77.2B$30.5B
Average P/E27.122.3
Dividend / Share--0.32%


XLV Health Care Select Sector SPDR® Fund
FHLC Fidelity® MSCI Health Care Index ETF
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.46%
NVS Novartis7.53%
PFE Pfizer6.88%
ABT Abbott Laboratories5.74%
MRK Merck5.18%
LLY Eli Lilly and Co5.07%
GSK GlaxoSmithKline4.99%
SNY Sanofi4.86%
ABBV AbbVie4.74%
BMY Bristol-Myers Squibb4.68%

Search for Jobs